Healthcare organizations are an extremely challenging and complex environment for innovation. But the need for them to innovate has never been more intense — whether in response to new entrants, changing customer behaviors, cost pressures, or shifting reimbursement paradigms.
Can you devote more of your organization’s resources and time to innovation? Move projects from pilot to roll-out faster? Involve constituencies that haven’t been traditionally been considered innovators? Create new incentives and reduce bureaucratic hurdles?
Our latest in-depth research report is geared to helping you answer all those questions in the affirmative. We explore how companies like CVS, Pfizer, Kaiser Permanente, Medtronic, Beckman Coulter, Merck, Cardinal Health, Bayer, AstraZeneca, Johns Hopkins, UnitedHealth Group, Johnson & Johnson, and others have set up new innovation initiatives that are delivering tangible results.
The 82-page PDF also includes survey data on questions like:
- Patient/consumer frustrations with healthcare
- Biggest barriers to innovation in healthcare organizations
- The players most likely to disrupt or impact healthcare over the coming decade
It also includes a diagram and questions to ask to help your organization improve how you source ideas, set up pilot tests, and scale what works. See the complete table of contents below.
This report is underwritten by The Nason Group, one of Innovation Leader’s strategic partners, and includes advice from Founder & CEO Shawn Nason on “The Role of Humanization in Disruption: Debunking Three Critical Myths.”